Cargando…

Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis

HIV-1 broadly neutralizing antibodies (bNAbs) targeting the viral envelope have shown significant promise in both HIV prevention and viral clearance, including pivotal results against sensitive strains in the recent Antibody Mediated Prevention (AMP) trial. Studies of bNAb passive transfer in infect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phelps, Meredith, Balazs, Alejandro Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479175/ https://www.ncbi.nlm.nih.gov/pubmed/34603314 http://dx.doi.org/10.3389/fimmu.2021.734304

Ejemplares similares

Antibody-based Protection Against HIV Infection by Vectored ImmunoProphylaxis
por: Balazs, Alejandro B., et al.
Publicado: (2011)

Broadly Neutralizing Antibodies for HIV-1 Prevention
por: Walsh, Stephen R., et al.
Publicado: (2021)

CD8 Effector T Cells Function Synergistically With Broadly Neutralizing Antibodies to Enhance Suppression of HIV Infection
por: Veenhuis, Rebecca T., et al.
Publicado: (2021)

HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function
por: Richardson, Simone I., et al.
Publicado: (2021)

Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1
por: Lin, Allen, et al.
Publicado: (2018)

Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV
por: Wilmschen, Sarah, et al.
Publicado: (2019)

Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity
por: Del Rosario, Joanne Marie M., et al.
Publicado: (2020)

Cross-reactive broadly neutralizing antibodies: timing is everything
por: Euler, Zelda, et al.
Publicado: (2012)

Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies Against HIV-1
por: Yu, Lei, et al.
Publicado: (2014)

Can Broadly Neutralizing HIV-1 Antibodies Help Achieve an ART-Free Remission?
por: Hsu, Denise C., et al.
Publicado: (2021)

Editorial: Novel Concepts in Using Broadly Neutralizing Antibodies for HIV-1 Treatment and Prevention
por: Wagh, Kshitij, et al.
Publicado: (2021)

The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage
por: Zhou, Jeffrey O., et al.
Publicado: (2020)

Vectored ImmunoProphylaxis Protects Humanized Mice from Mucosal HIV Transmission
por: Balazs, Alejandro B., et al.
Publicado: (2014)

Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
por: Balazs, AB, et al.
Publicado: (2012)

CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques
por: Sarkar, Sanghita, et al.
Publicado: (2021)

The Antibody Germline/Maturation Hypothesis, Elicitation of Broadly Neutralizing Antibodies Against HIV-1 and Cord Blood IgM Repertoires
por: Prabakaran, Ponraj, et al.
Publicado: (2014)

Corrigendum: The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage
por: Zhou, Jeffrey O., et al.
Publicado: (2020)

Broadly Neutralizing Antibodies for HIV Eradication
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

Passive Broad-Spectrum Influenza Immunoprophylaxis
por: Berry, Cassandra M., et al.
Publicado: (2014)

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
por: Richardson, Simone I., et al.
Publicado: (2018)

Convergent antibody responses are associated with broad neutralization of hepatitis C virus
por: Skinner, Nicole E., et al.
Publicado: (2023)

Immunoprophylaxis in fish by injection of mouse antibody genes
por: Lorenzen, Niels, et al.
Publicado: (2000)

Combinations of Single Chain Variable Fragments From HIV Broadly Neutralizing Antibodies Demonstrate High Potency and Breadth
por: van Dorsten, Rebecca T., et al.
Publicado: (2021)

Modeling HIV-1 Within-Host Dynamics After Passive Infusion of the Broadly Neutralizing Antibody VRC01
por: Cardozo-Ojeda, E. Fabian, et al.
Publicado: (2021)

Autoreactivity and broad neutralization of antibodies against HIV-1 are governed by distinct mutations: Implications for vaccine design strategies
por: Li, Xiaojun, et al.
Publicado: (2022)

HIV vaccine development and broadly neutralizing antibodies
por: Greenspan, Neil S., et al.
Publicado: (2015)

The expanding array of HIV broadly neutralizing antibodies
por: McCoy, Laura E.
Publicado: (2018)

Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021)

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
por: Shrestha, Lok Bahadur, et al.
Publicado: (2021)

Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus
por: Skinner, Nicole E., et al.
Publicado: (2023)

Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic
por: Spencer, David A., et al.
Publicado: (2021)

HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model
por: Siracusano, Gabriel, et al.
Publicado: (2021)

Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers
por: Nyanhete, Tinashe E., et al.
Publicado: (2021)

Analysis of two cooperating antibodies unveils immune pressure imposed on HIV Env to elicit a V3-glycan supersite broadly neutralizing antibody lineage
por: Finkelstein, Maxwell T., et al.
Publicado: (2022)

A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch
por: Wang, Zijun, et al.
Publicado: (2020)

Neutralization-Enhancing RF Antibodies for HIV Vaccines
por: Suslov, Konstantin V.
Publicado: (2014)

IgY antibodies for the immunoprophylaxis and therapy of respiratory infections
por: Abbas, Aymn Talat, et al.
Publicado: (2018)

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
por: Richardson, Simone I., et al.
Publicado: (2019)

Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application
por: Ding, Chengchao, et al.
Publicado: (2021)

Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
por: Lee, Wen Shi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_icpfm2lbg5p9qsf02jh9m04kkn